Accepted Manuscript Virucidal activity of WHO-recommended formulations against enveloped viruses including Zika, Ebola and emerging Coronaviruses Anindya Siddharta1*, Stephanie Pfaender2,3*, Nathalie Jane Vielle2,3,4, Ronald Dijkman2,3, Martina Friesland1, Britta Becker5, Jaewon Yang6, Michael Engelmann1, Daniel Todt1, Marc P. Windisch6, Florian H. Brill5, Joerg Steinmann7, Jochen Steinmann5, Stephan Becker8, Marco P. Alves2,3, Thomas Pietschmann1, Markus Eickmann8, Volker Thiel2,3, Eike Steinmann1# *equally contributed 1Institute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research; a joint venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Germany 2Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland 3Federal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland 4Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland 5Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology, Bremen, Germany 6Applied Molecular Virology, Institut Pasteur Korea, Seongnam, Gyeonggi-do, South Korea 7Institute of Medical Microbiology, University Hospital Essen, University Duisburg- Essen, Germany 8Institute for Virology, Philipps University of Marburg, Marburg, Germany © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creative commons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact